Drawing for AFFITOPE

USPTO serial 79029262

AFFITOPE

Reviewed by CopyMark Law Group

Reg. 3405654Status 709
Filing date
Status date
Registration date
Apr 1, 2008
Examiner
BLANE, SUZANNE
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AFFITOPE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001[ Chemical preparations for use in industry, science and laboratories; biological preparations for use in industry, science and laboratories, namely, for use in research, analysis and diagnostics, namely,, bacteria for use in connection with the research of epitopes and antigenes as well-as for prophylaxis and therapy of medical conditions ]SECTION 71 - CANCELLED—
005[ Pharmaceutical and veterinary preparations, namely, for treatment of infectious diseases, auto-immune diseases, dementia diseases, namely, Alzheimer's disease or arteriosclerotic diseases; vaccines; diagnostic preparations for medical purposes; chemical reagents for medical and veterinary purposes; chemical and biological preparations for medical use ]SECTION 71 - CANCELLED—
010[ Surgical, medical, dental and veterinary instruments and apparatus as well as replacement parts of the aforementioned goods, namely, instruments and apparatus for use in therapy and prophylaxis of medical conditions, namely, for use in general surgery; medical apparatus and instruments, namely, for use in therapy and prophylaxis of medical conditions, namely, for treatment of infectious diseases, auto-immune diseases, dementia diseases, namely, Alzheimer's disease or arteriosclerotic diseases; apparatus for use in medical analysis, namely, for use in therapy and prophylaxis of medical conditions, namely, for blood analysis for clinical diagnosis ]SECTION 71 - CANCELLED—
042Development or medical diagnostic, therapy and test methods, namely, conducting clinical trials, scientific investigations for medical purposes, research in the field of chemical medicine, pharmaceutics and bacteriologySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 5, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 11, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 1, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 29, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 28, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 27, 2019INPCINVALIDATION PROCESSED—
Jul 2, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 2, 2018C71TCANCELLED SECTION 71—
Apr 1, 2017REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jun 30, 2016RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 20, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Apr 9, 2015XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Apr 9, 2015XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 7, 2014INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 7, 2014NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 7, 201471.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Feb 7, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 23, 201471AFREGISTERED-SEC.71 FILED—
Jan 23, 2014ES71TEAS SECTION 71 RECEIVED—
Dec 22, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 4, 2011ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 17, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 17, 2008FIMPFINAL DISPOSITION PROCESSED—
Jul 3, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 1, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 15, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 26, 2007NPUBNOTICE OF PUBLICATION—
Dec 12, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 11, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 8, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 8, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 8, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2007CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 14, 2007CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 25, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 25, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2007MAILPAPER RECEIVED—
Jun 22, 2007CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 21, 2007CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 30, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 30, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 30, 2007ALIEASSIGNED TO LIE—
May 29, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 11, 2007MAILPAPER RECEIVED—
Dec 8, 2006RFNTREFUSAL PROCESSED BY IB—
Nov 21, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 21, 2006RFRRREFUSAL PROCESSED BY MPU—
Nov 18, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 17, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2006DOCKASSIGNED TO EXAMINER—
Nov 3, 2006NWAPNEW APPLICATION ENTERED—
Nov 2, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance